Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 15;35(2):131-140.
doi: 10.4274/balkanmedj.2017.1635.

Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation

Güldane Cengiz Seval  1 , Pervin Topçuoğlu  1 , Taner Demirer  1
Affiliations
Review

Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation

Güldane Cengiz Seval et al. Balkan Med J. .

Abstract

Hematopoietic stem cell transplantation is an established treatment for patients with a wide range of malignant and nonmalignant conditions. Noninfectious pulmonary complications still remain a leading cause of morbidity and mortality in these patients. Treating hematopoietic stem cell transplantation recipients with noninfectious pulmonary complications is still challenging, and the current treatment armamentarium and strategies are not adequate for patients receiving hematopoietic stem cell transplantation. Further trials are needed for a better description of the pathogenesis and the complete diagnostic criteria as well as for the development of effective therapeutic approaches for the management of noninfectious pulmonary complications of the hematopoietic stem cell transplantation. This review outlines the incidence, risk factors, pathogenesis, and clinical spectrum and discusses the current approaches to the management of noninfectious pulmonary complications of Hematopoietic stem cell transplantation.

Keywords: Bronchiolitis Obliterans syndrome Idiopathic Pneumonia syndrome.; Hematopoietic stem cell transplantation; pulmonary complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The timeline of the primary pulmonary complications following [Chi et al. (19)]. BOS: Bronchiolitis Obliterans syndrome; BOOP: bronchiolitis obliterans organizing pneumonia; CHF: congestive heart failure; DAH: diffuse alveolar hemorrhage; DPTS: Delayed Pulmonary Toxicity syndrome; GVHD: graft versus host disease IPS: Idiopathic Pneumonia syndrome; PCT: pulmonary cytolytic thrombi; PERDS: Periengraftment Respiratory Distress syndrome; PTLPD: post-transplant lymphoproliferative disorder; PVOD: pulmonary veno-occlusive disease
Figure 2
Figure 2. An algorithmic approach to the management of pulmonary complications after hematopoietic stem cell transplantation [Afessa et al. (7)].
See this image and copyright information in PMC

References

    1. Demirer T, Peterson FB, Bensinger WI, Appelbaum FR, Fefer A, Rowley S, et al. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia. Bone Marrow Transplantat. 1996;18:29–34. - PubMed
    1. Peccatori J, Barkholt L, Demirer T, Sormani MP, Bruzzi P, Ciceri F, et al. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation. Cancer. 2005;104:2099–103. - PubMed
    1. Demirer T, Celebi H, Arat M, Ustün C, Demirer S, Dilek I, et al. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;24:335–7. - PubMed
    1. De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, et al. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. Br J Cancer. 2005;93:412–7. - PMC - PubMed
    1. Pedrazzoli P, Ferrante P, Kulekci A, Schiavo R, De Giorgi U, Carminati O, et al. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999. Bone Marrow Transplant. 2003;32:489–94. - PubMed